The Need for Technologies to Prevent Bilirubin-Induced Neurologic Dysfunction Syndrome

Seminars in Perinatology

Volumn 35, Issue 3, 2011, Pages 97-100

  Bhutani, Vinod K ^a,b   Stevenson, David K ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

Affordable technologies; Bilirubin binding; Bilirubin production; Bilirubin induced neurologic dysfunction; Kernicterus; Newborn jaundice; Phototherapy

Indexed keywords

BILIRUBIN;

ACUTE BRAIN DISEASE; BILIRUBIN BINDING; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; EVOKED VISUAL RESPONSE; HEALTH CARE NEED; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; VESTIBULOCOCHLEAR NERVE DISEASE;

BILIRUBIN; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; KERNICTERUS; NERVOUS SYSTEM DISEASES;

EID: 79957938585     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.02.002     Document Type: Review

References (16)

1. Dennery P.A., Seidman D.S., Stevenson D.K. Neonatal hyperbilirubinemia. N Engl J Med 2001, 344:581-590.
2. Clinical Practice Guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004, 114:297-316. American Academy of Pediatrics.
3. Bhutani V.K., Vilms R.J., Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol 2010, 30(suppl):S6-S15.
4. Maisels M.J. Neonatal jaundice. Pediatr Rev 2006, 27:443-454.
5. Johnson L., Bhutani V.K., Karp K., et al. Clinical report from the pilot USA Kernicterus Registry (1992-2004). J Perinatol 2009, 29(suppl 1):S25-S45.
6. Kuzniewicz M., Newman T.B. Interaction of hemolysis and hyperbilirubinemia on neurodevelopmental outcomes in the collaborative perinatal project. Pediatrics 2009, 123:1045-1050.
7. Bhutani V.K., Johnson L.H., Shapiro S.M. 2001 22: Kernicterus in sick and preterm infants (1999-2002): A need for an effective preventive approach. Semin Perinatol 2004, 28:319-325.
8. Wennberg R.P., Ahlfors C.E., Bhutani V.K., et al. Toward understanding kernicterus: A challenge to improve the management of jaundiced newborns. Pediatrics 2006, 117:474-485.
9. Penn A.A., Enzmann D.R., Hahn J.S., et al. Kernicterus in a full term infant. Pediatrics 1994, 93:1003-1006.
10. Volpe J.J. Bilirubin and brain injury. Neurology of the Newborn 2011, 619-651. Saunders, Philadelphia. (edn 5). J.J. Volpe (Ed.).
11. Shapiro S.M., Bhutani V.K., Johnson L. Hyperbilirubinemia and kernicterus. Clin Perinatol 2006, 33:387-410.
12. Johnson L., Brown A.K., Bhutani V.K. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002, 93:488-494.
13. Good W.V., Hou C. Sweep visual evoked potential grating acuity thresholds paradoxically improve in low-luminance conditions in children with cortical visual impairment. Invest Ophthalmol Vis Sci 2006, 47:3220-3224.
14. Robertson W.O., Almquist J.R., Light I.J., et al. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994, 94:558-565. American Academy of Pediatrics Provisional Committee for Quality Improvement.
15. Newman T.B., Liljestrand P., Jeremy R.J., et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006, 354:1889-1900. Jaundice and Infant Feeding Study Team.
16. Trikalinos T.A., Chung M., Lau J., et al. Systematic review of screening for bilirubin encephalopathy in neonates. Pediatrics 2009, 124:1162-1171.